Life ScienceCompany
Par Pharmaceutical - Research and Development Capabilities Ownership
Who owns Par Pharmaceutical - Research and Development Capabilities?
Par Pharmaceutical - Research and Development Capabilities is owned by Alvogen. It was acquired on October 22, 2009.
Par Pharmaceutical - Research and Development Capabilities Business Overview
Where is Par Pharmaceutical - Research and Development Capabilities headquartered?
Par Pharmaceutical - Research and Development Capabilities is headquartered in United States.
What sector is Par Pharmaceutical - Research and Development Capabilities in?
Par Pharmaceutical - Research and Development Capabilities is a life science company.
Life Science M&A Summary in 2009
Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009. The largest life science acquisition in 2009 was Wyeth - which was acquired by Pfizer for $68.0B.
Join Mergr to view all 111 acquisitions of life science companies in 2009, including 13 acquisitions by private equity firms, and 98 by strategics.